STAAR Surgical

STAAR® Surgical Company, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or “ICL.” A lens used to replace the natural lens after cataract surgery is called an intraocular lens or “IOL.” Over 500,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: STAAR has approximately 300 full time employees and markets lenses in over 70 countries. Headquartered in Monrovia, CA, conducts operations in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA.
Monrovia, US
Size (employees)
336 (est)-6%
STAAR Surgical was founded in 1982 and is headquartered in Monrovia, US

STAAR Surgical Office Locations

STAAR Surgical has offices in Monrovia, Nidau
Monrovia, US
Nidau, CH

STAAR Surgical Metrics

STAAR Surgical Summary

Market capitalization

$395.3 m

Closing share price

STAAR Surgical's current market capitalization is $395.3 m.

STAAR Surgical Financials

STAAR Surgical's revenue is $72.2 m in FY, 2013 which is a 3.7% decrease from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016


$72.2 m$75 m$77.1 m$82.4 m

Revenue growth, %


Gross profit

$50.3 m$48.8 m$52.7 m


$700 k($8 m)($5.3 m)

Net Income

$398 k($8.4 m)($6.5 m)($12.1 m)

Operating cash flow

$1.3 m($9.9 m)$389 k

STAAR Surgical Market Value History

STAAR Surgical Job Categories

STAAR Surgical Online Presence

STAAR Surgical Company Life

You may also be interested in